Abstract:Revealing the interaction mechanisms between anticancer drugs and target DNA molecules at the single-molecule level is a hot research topic in the interdisciplinary fields of biophysical chemistry and pharmaceutical engineering. When fluorescence imaging technology is employed to carry out this kind of research, a knotty problem due to fluorescent dye molecules and drug molecules acting on a DNA molecule simultaneously is encountered. In this paper, based on self-made novel solid active substrates NpAA/(ZnO-ZnCl2)/AuNPs, we use a surface-enhanced Raman spectroscopy method, inverted fluorescence microscope technology, and a molecular docking method to investigate the action of the fluorescent dye YOYO-1 and the drug DOX on calf thymus DNA (ctDNA) molecules and the influencing effects and competitive relationships of YOYO-1 on the binding properties of the ctDNA-DOX complex. The interaction sites and modes of action between the YOYO-1 and the ctDNA-DOX complex are systematically examined, and the DOX with the ctDNA-YOYO-1 are compared, and the impact of YOYO-1 on the stability of the ctDNA-DOX complex and the competitive mechanism between DOX and YOYO-1 acting with DNA molecules are elucidated. This study has helpful experimental guidance and a theoretical foundation to expound the mechanism of interaction between drugs and biomolecules at the single-molecule level.

What problem does this paper attempt to address?

### Problems the Paper Aims to Address This paper aims to investigate the impact of the fluorescent dye YOYO-1 on the binding characteristics of the anticancer drug Doxorubicin (DOX) with DNA molecules and its competitive mechanism. Specifically: 1. **Interaction between the drug and DNA**: - Doxorubicin, as a widely used antitumor drug, has shown significant efficacy in the treatment of various cancers. However, its interaction mechanism with DNA at the single-molecule level is not fully understood, especially its potential side effects such as cardiotoxicity, which limit its clinical application. 2. **Issues in fluorescence imaging technology**: - When using fluorescence imaging technology to study drug-DNA interactions, it is usually necessary to label with fluorescent dyes (such as YOYO-1). In this case, the fluorescent dye YOYO-1 and drug molecules (such as DOX) will simultaneously bind to DNA molecules, leading to the possibility that YOYO-1 may affect the interaction between DOX and DNA, thereby affecting the accuracy and sensitivity of fluorescence imaging results. 3. **Application of Surface-Enhanced Raman Spectroscopy (SERS)**: - To overcome the above issues, researchers utilized a self-made novel solid active substrate NpAA/(ZnO-ZnCl2)/AuNPs, combined with Surface-Enhanced Raman Spectroscopy (SERS), inverted fluorescence microscopy technology, and molecular docking methods to study the effects and competitive relationship of YOYO-1 and DOX on calf thymus DNA (ctDNA). Through these methods, the paper reveals the impact of YOYO-1 on the stability of the ctDNA-DOX complex and its competitive mechanism with DOX, providing experimental guidance and theoretical basis for elucidating the interaction mechanism of drugs and biomolecules at the single-molecule level.

Studying the Effects and Competitive Mechanisms of YOYO-1 on the Binding Characteristics of DOX and DNA Molecules Based on Surface-Enhanced Raman Spectroscopy and Molecular Docking Techniques

The Mechanism of Dynamic Interaction Between Doxorubicin and Calf Thymus DNA at the Single-Molecule Level Based on Confocal Raman Spectroscopy.

Synergistic Effects and Competitive Relationships Between DOC and DOX As Acting on DNA Molecules: Studied with Confocal Raman Spectroscopy and Molecular Docking Technology

Thermodynamics, in Vitro Release and Cytotoxity Studies on Doxorubicin–toluidine Blue O Combination Drugs Co-Loaded in Aptamer-Tethered DNA Nanostructures

Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy

Electrochemical Study on Synergistic Effect of the Blending of Nano TiO2 and PLA Polymer on the Interaction of Antitumor Drug with DNA

DOX-DNA Interactions on the Nanoscale: In Situ Studies Using Tip-Enhanced Raman Scattering

Nanopore Single-Molecule Analysis of Dna Doxorubicin Interactions

Fluorescence Anisotropy Analysis of the Interaction between Doxorubicin and DNA Origami Nanostructures

Nanocomplexes of Doxorubicin and DNA Fragments for Efficient and Safe Cancer Chemotherapy.

An Analysis Method for Simultaneous Screening of Deoxyribonucleic Acid-Binding Active Compounds and Investigating Their Mechanisms by Ultra-Fast Liquid Chromatography Tandem Mass Spectrometry Coupled with Fluorescence Detection Technology.

Rational Design of DNA Framework‐Based Hybrid Nanomaterials for Anticancer Drug Delivery

Self-assembly of DNA Nanospheres with Controllable Size and Self-Degradable Property for Enhanced Antitumor Chemotherapy

A Direct Approach Toward Investigating DNA-ligand Interactions Via Surface-Enhanced Raman Spectroscopy Combined with Molecular Dynamics Simulations.

Unveiling the multifaceted interactions of antitumor drug mitoxantrone with ct-DNA through biophysical and in silico studies

DNA Origami–Anthraquinone Hybrid Nanostructures for In Vivo Quantitative Monitoring of the Progression of Tumor Hypoxia Affected by Chemotherapy

Ph-Sensitive Deoxycholic Acid Dimer for Improving Doxorubicin Delivery and Antitumor Activity in Vivso.

DNA Origami As an in Vivo Drug Delivery Vehicle for Cancer Therapy

NIR/pH-triggered aptamer-functionalized DNA origami nanovehicle for imaging-guided chemo-phototherapy

Biophysical characterization of DNA origami nanostructures reveals inaccessibility to intercalation binding sites

In Situ Surface-Enhanced Raman Scattering Spectroscopy Exploring Molecular Changes of Drug-Treated Cancer Cell Nucleus